Literature DB >> 16572495

Single nucleotide polymorphisms in the proximal promoter region of apolipoprotein M gene (apoM) confer the susceptibility to development of type 2 diabetes in Han Chinese.

Nifang Niu1, Xilin Zhu, Yang Liu, Te Du, Xin Wang, Dongmei Chen, Bei Sun, Harvest F Gu, Ying Liu.   

Abstract

OBJECTIVE: Dyslipidemia correlating to insulin resistance is one of the key features in type 2 diabetes (T2D). Recent studies have demonstrated that apolipoprotein M (apoM) is important for the formation of prebeta-high-density lipoprotein (HDL) and cholesterol (CHO) efflux in macrophages to HDL. In the present study, we investigated the potential association of apoM genetic variation with the development of T2D.
METHODS: Single nucleotide polymorphisms (SNPs) C-1065A, T-855C and T-778C in the proximal promoter region of apoM gene were validated to represent in Han Chinese. Further genotyping experiments in 170 T2D patients and 156 non-diabetic control subjects were performed with polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP).
RESULTS: Single marker analysis for SNP T-778C indicated that T2D patients had increased frequency of C allele in comparison with non-diabetic controls (10.6% versus 5.8%, P = 0.026, OR = 1.934). In non-diabetic controls, the carriers with CT and CC genotypes had higher plasma CHO (221.7 versus 204.2 mg/dL, P = 0.033) and fasting plasma glucose (FPG) (92.6 versus 89.7 mg/dL, P = 0.041) levels than the subjects with TT genotype. Further analysis with adjustment for age, BMI, SBP, DBP, CHO and TG demonstrated that this SNP was strongly associated with T2D (P = 0.013, OR = 2.287). Haplotype analysis for those three SNPs, however, indicated that the common haplotypes were less informative than studying the role of the T-778C variant independently of the haplotype context.
CONCLUSION: The present study provided the first evidence that SNP T-778C in the proximal promoter region of apoM gene was associated with the levels of plasma CHO and FPG and also conferred the risk in the development of T2D among Han Chinese.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 16572495     DOI: 10.1002/dmrr.641

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  21 in total

1.  Association of apolipoprotein M gene polymorphisms with ischemic stroke in a Han Chinese population.

Authors:  Dongxue Zhao; Zhiyi He; Xue Qin; Lei Li; Fang Liu; Shumin Deng
Journal:  J Mol Neurosci       Date:  2010-09-25       Impact factor: 3.444

2.  Regulation of human apolipoprotein m gene expression by orphan and ligand-dependent nuclear receptors.

Authors:  Ioanna Mosialou; Vassilis I Zannis; Dimitris Kardassis
Journal:  J Biol Chem       Date:  2010-07-26       Impact factor: 5.157

3.  Determination of single-nucleotide polymorphism in the proximal promoter region of apolipoprotein M gene in coronary artery diseases.

Authors:  Lu Zheng; Guanghua Luo; Xiaoying Zhang; Jun Zhang; Jiang Zhu; Jiang Wei; Qinfeng Mu; Lujun Chen; Peter Nilsson-Ehle; Ning Xu
Journal:  Int J Gen Med       Date:  2009-12-29

4.  Tissue-specific and ubiquitous expression patterns from alternative promoters of human genes.

Authors:  Edwin Jacox; Valer Gotea; Ivan Ovcharenko; Laura Elnitski
Journal:  PLoS One       Date:  2010-08-18       Impact factor: 3.240

5.  Apolipoprotein M gene (APOM) polymorphism modifies metabolic and disease traits in type 2 diabetes.

Authors:  Jun-Wei Zhou; Stephen K W Tsui; Maggie C Y Ng; Hua Geng; Sai-Kam Li; Wing-Yee So; Ronald C Ma; Ying Wang; Qian Tao; Zhen-Yu Chen; Juliana C N Chan; Yuan-Yuan Ho
Journal:  PLoS One       Date:  2011-02-24       Impact factor: 3.240

6.  Hyperglycemia-induced downregulation of apolipoprotein M expression is not via the hexosamine pathway.

Authors:  Bo Jiang; Xiaoying Zhang; Dongmei Di; Guanghua Luo; Yuanping Shi; Jun Zhang; Maria Berggren-Söderlund; Peter Nilsson-Ehle; Ning Xu
Journal:  Lipids Health Dis       Date:  2015-09-16       Impact factor: 3.876

7.  Functional study of -724I/D polymorphism in apolipoprotein M (apoM) gene promoter region and its association with myocardial infarction.

Authors:  Hua Guo; Xian-Xian Zhao; Xiao-Juan Zhang; Wei Chen; Jie Zhang
Journal:  Med Sci Monit       Date:  2015-01-31

8.  Modulation of sphingosine-1-phosphate and apolipoprotein M levels in the plasma, liver and kidneys in streptozotocin-induced diabetic mice.

Authors:  Takahiro Nojiri; Makoto Kurano; Yasunori Tokuhara; Shigeo Ohkubo; Masumi Hara; Hitoshi Ikeda; Kazuhisa Tsukamoto; Yutaka Yatomi
Journal:  J Diabetes Investig       Date:  2014-04-21       Impact factor: 4.232

9.  A single-nucleotide polymorphism in the proximal promoter region of the apolipoprotein M gene is associated with dyslipidaemia but not increased coronary artery diseases in Chinese populations.

Authors:  Bing Cao; Yi Zhou Ye; Jun Rui; Ming Qiu Li; Wei Wang; Liu Yan Wei; Guo Qing Jiao
Journal:  Lipids Health Dis       Date:  2013-12-16       Impact factor: 3.876

10.  Apolipoprotein M T-778C polymorphism is associated with serum lipid levels and the risk of coronary artery disease in the Chinese population: a meta-analysis.

Authors:  Zhi Zhang; Guang Chu; Rui-Xing Yin
Journal:  Lipids Health Dis       Date:  2013-09-16       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.